GlassScriptPhysician profile
Akas Jain
NPI 1215017785
$4,881.57
in general payments reported to CMS, 2019-2025
18 companies · $511 in 2025
The $511 reported for 2025 was more than what 87% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,339 · 2020: $434 · 2021: $799 · 2022: $453 · 2023: $466 · 2024: $879 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,856.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $1,076.01 | 2021-2025 | Ganirelix Acetate, Pregnyl, Follistim Aq |
| Coopersurgical, INC. | $619.14 | 2019-2024 | Stripper |
| Hologic Sales and Service, LLC | $473.60 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Ferring Pharmaceuticals INC. | $470.20 | 2019-2025 | Menopur |
| Merck Sharp & Dohme LLC | $398.44 | 2019-2021 | |
| Emd Serono, INC. | $326.28 | 2019-2023 | |
| Myovant Sciences INC. | $269.10 | 2021-2022 | |
| Medical Device Business Services, INC. | $216.81 | 2019-2024 | Enseal |
| Abbvie INC. | $184.28 | 2019-2020 | |
| Sage Therapeutics, LLC | $159.96 | 2024 | |
| Minerva Surgical, INC | $138.46 | 2022-2024 | |
| Tesaro, INC. | $125.00 | 2019 | |
| Astellas Pharma US INC | $125.00 | 2023 | Veozah |
| Biogen, INC. | $120.09 | 2024-2025 | Zurzuvae |
| Galen US INC | $94.00 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $37.22 | 2019-2025 | |
| Gynesonics, INC. | $31.53 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Covidien LP | $16.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akas Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.